Barclays’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$366M Sell
822,937
-2,993
-0.4% -$1.33M 0.08% 125
2025
Q1
$400M Sell
825,930
-17,145
-2% -$8.31M 0.11% 112
2024
Q4
$340M Sell
843,075
-96,261
-10% -$38.8M 0.1% 116
2024
Q3
$437M Buy
939,336
+93,674
+11% +$43.6M 0.12% 107
2024
Q2
$396M Buy
845,662
+28,247
+3% +$13.2M 0.12% 109
2024
Q1
$342M Buy
817,415
+10,656
+1% +$4.45M 0.12% 124
2023
Q4
$328M Buy
806,759
+550
+0.1% +$224K 0.12% 118
2023
Q3
$280M Buy
806,209
+170,224
+27% +$59.2M 0.17% 123
2023
Q2
$224M Buy
635,985
+199,923
+46% +$70.4M 0.14% 138
2023
Q1
$137M Sell
436,062
-175,725
-29% -$55.4M 0.06% 152
2022
Q4
$177M Buy
611,787
+198,887
+48% +$57.4M 0.08% 141
2022
Q3
$120M Buy
412,900
+31,812
+8% +$9.21M 0.13% 153
2022
Q2
$107M Sell
381,088
-190,947
-33% -$53.8M 0.07% 168
2022
Q1
$149M Sell
572,035
-8,563
-1% -$2.23M 0.12% 168
2021
Q4
$128M Buy
580,598
+11,895
+2% +$2.61M 0.05% 223
2021
Q3
$103M Buy
568,703
+147,497
+35% +$26.8M 0.05% 241
2021
Q2
$84.9M Buy
421,206
+44,907
+12% +$9.05M 0.04% 264
2021
Q1
$80.9M Sell
376,299
-69,698
-16% -$15M 0.04% 243
2020
Q4
$105M Buy
445,997
+59,702
+15% +$14.1M 0.06% 172
2020
Q3
$105M Buy
386,295
+53,203
+16% +$14.5M 0.06% 155
2020
Q2
$96.7M Sell
333,092
-349,050
-51% -$101M 0.07% 127
2020
Q1
$162M Sell
682,142
-83,769
-11% -$19.9M 0.13% 70
2019
Q4
$168M Buy
765,911
+342,430
+81% +$75M 0.09% 112
2019
Q3
$71.7M Buy
423,481
+65,385
+18% +$11.1M 0.04% 237
2019
Q2
$65.7M Buy
358,096
+90,157
+34% +$16.5M 0.04% 279
2019
Q1
$49.3M Sell
267,939
-77,090
-22% -$14.2M 0.03% 295
2018
Q4
$57.2M Sell
345,029
-110,037
-24% -$18.2M 0.04% 223
2018
Q3
$87.7M Buy
455,066
+151,996
+50% +$29.3M 0.06% 168
2018
Q2
$51.5M Sell
303,070
-162,581
-35% -$27.6M 0.04% 241
2018
Q1
$75.9M Buy
465,651
+63,770
+16% +$10.4M 0.06% 197
2017
Q4
$60.2M Buy
401,881
+134,325
+50% +$20.1M 0.05% 215
2017
Q3
$40.7M Buy
267,556
+77,465
+41% +$11.8M 0.04% 227
2017
Q2
$24.5M Buy
190,091
+9,662
+5% +$1.25M 0.03% 297
2017
Q1
$19.7M Buy
180,429
+68,354
+61% +$7.47M 0.02% 335
2016
Q4
$8.26M Buy
112,075
+21,249
+23% +$1.57M 0.01% 574
2016
Q3
$7.92M Sell
90,826
-8,746
-9% -$763K 0.01% 534
2016
Q2
$8.57M Buy
99,572
+1,684
+2% +$145K 0.01% 522
2016
Q1
$7.73M Sell
97,888
-26,294
-21% -$2.08M 0.01% 522
2015
Q4
$15.5M Sell
124,182
-4,737
-4% -$592K 0.02% 356
2015
Q3
$13.4M Sell
128,919
-51,112
-28% -$5.32M 0.02% 406
2015
Q2
$22.1M Sell
180,031
-22,017
-11% -$2.71M 0.02% 330
2015
Q1
$23.6M Buy
202,048
+2,414
+1% +$282K 0.03% 365
2014
Q4
$23.6M Buy
199,634
+16,501
+9% +$1.95M 0.02% 367
2014
Q3
$20.5M Sell
183,133
-240,278
-57% -$26.9M 0.02% 387
2014
Q2
$39.8M Buy
423,411
+165,349
+64% +$15.5M 0.04% 221
2014
Q1
$18.1M Sell
258,062
-336,060
-57% -$23.5M 0.02% 449
2013
Q4
$44M Sell
594,122
-154,489
-21% -$11.4M 0.05% 221
2013
Q3
$56.1M Buy
748,611
+122,813
+20% +$9.21M 0.07% 143
2013
Q2
$50.1M Buy
+625,798
New +$50.1M 0.06% 141